A consortium of new and previous backers led by Life Sciences Partners (LSP) has invested $38.5m in France-based DNA Script, a manufacturer of synthetic DNA.
DVI Equity Partners, Frontline Ventures and Enterprise Ireland also take part
Newcomer Target Global and existing investor Round Hill Ventures also take part in the round
GP invests €7.3m in the France-based point-of-sale merchandising equipment provider
Azimut appoints Jeffry Brown as CEO of AACP; Brown previously worked at Dyal Capital Partners